共 166 条
[41]
Ritchlin CT(2012)Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotypes? Curr Rheumatol Rep 17 1213-199
[42]
Mease PJ(2016)European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Ann Rheum Dis 65 192-202
[43]
Mease PJ(2015)Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype Arthritis Care Res 44 201-403
[44]
Heckaman M(2013)Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor alpha inhibitor therapy: results from the Danish Nationwide DANBIO Registry Arthritis Rheum 372 401-405
[45]
Kary S(2015)Two-year survival rates of anti-TNF-alpha therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA Scand J Rheumatol 375 403-409
[46]
Kupper H(2015)Sharing individual patient data from clinical trials N Engl J Med 375 407-864
[47]
Coates LC(2016)Strengthening research through data sharing N Engl J Med 375 859-1236
[48]
Moverley AR(2016)The Yale Open Data Access (YODA) Project—a mechanism for data sharing N Engl J Med 64 1227-1645
[49]
McParland L(2016)Sharing data from cardiovascular clinical trials—a proposal N Engl J Med 52 1638-173
[50]
Ogdie A(2005)A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis Ann Rheum Dis 54 164-548